330 related articles for article (PubMed ID: 20308469)
21. MR imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety.
Juluru K; Vogel-Claussen J; Macura KJ; Kamel IR; Steever A; Bluemke DA
Radiographics; 2009; 29(1):9-22. PubMed ID: 19019996
[TBL] [Abstract][Full Text] [Related]
22. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
Weinreb JC; Abu-Alfa AK
J Magn Reson Imaging; 2009 Dec; 30(6):1236-9. PubMed ID: 19938035
[TBL] [Abstract][Full Text] [Related]
23. Pathomechanisms of nephrogenic systemic fibrosis: new insights.
Gupta A; Shamseddin MK; Khaira A
Clin Exp Dermatol; 2011 Oct; 36(7):763-8. PubMed ID: 21790732
[TBL] [Abstract][Full Text] [Related]
24. Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium - 1997-2006-2016. Part 1.
Thomsen HS
Acta Radiol; 2016 May; 57(5):515-20. PubMed ID: 26802069
[No Abstract] [Full Text] [Related]
25. Re: chemical structure and stability of gadolinium chelates.
Idée JM; Port M; Corot C
Radiographics; 2009 Nov; 29(7):2099. PubMed ID: 19926764
[No Abstract] [Full Text] [Related]
26. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.
Idée JM; Port M; Dencausse A; Lancelot E; Corot C
Radiol Clin North Am; 2009 Sep; 47(5):855-69, vii. PubMed ID: 19744600
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.
Yee J
Adv Chronic Kidney Dis; 2017 May; 24(3):133-135. PubMed ID: 28501073
[No Abstract] [Full Text] [Related]
28. [Gadolinium and nephrogenic systemic fibrosis. All quiet? Yes...! No...! Maybe...!].
Balducci A; Tamburrini O
G Ital Nefrol; 2011; 28(1):4-6. PubMed ID: 21341233
[No Abstract] [Full Text] [Related]
29. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
Boyd AS; Sanyal S; Abraham JL
J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
[TBL] [Abstract][Full Text] [Related]
30. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Bertero M; Bainotti S; Comino A; Formica M; Giordano F; Musso L; Palazzini S; Seia Z
Eur J Dermatol; 2009; 19(1):73-4. PubMed ID: 19171533
[No Abstract] [Full Text] [Related]
31. Renal failure and gadolinium. The number of documented cases is rising.
Prescrire Int; 2008 Oct; 17(97):205. PubMed ID: 19537311
[No Abstract] [Full Text] [Related]
32. Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the Food and Drug Administration.
Yang L; Krefting I; Gorovets A; Marzella L; Kaiser J; Boucher R; Rieves D
Radiology; 2012 Oct; 265(1):248-53. PubMed ID: 22923714
[TBL] [Abstract][Full Text] [Related]
33. Rehabilitation in nephrogenic systemic fibrosis.
Ramaizel L; Sliwa JA
PM R; 2009 Jul; 1(7):684-6. PubMed ID: 19627963
[No Abstract] [Full Text] [Related]
34. Update on nephrogenic systemic fibrosis.
Thomsen HS; Marckmann P; Logager VB
Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):551-60, vii. PubMed ID: 18926421
[TBL] [Abstract][Full Text] [Related]
35. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Kitajima K; Maeda T; Watanabe S; Ueno Y; Sugimura K
Int J Urol; 2012 Sep; 19(9):806-11. PubMed ID: 22571387
[TBL] [Abstract][Full Text] [Related]
36. Ocular pathologic features and gadolinium deposition in nephrogenic systemic fibrosis.
Barker-Griffith A; Goldberg J; Abraham JL
Arch Ophthalmol; 2011 May; 129(5):661-3. PubMed ID: 21555622
[No Abstract] [Full Text] [Related]
37. Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium - 1997-2006-2016. Part 2.
Thomsen HS
Acta Radiol; 2016 Jun; 57(6):643-8. PubMed ID: 26802070
[No Abstract] [Full Text] [Related]
38. Nephrogenic systemic fibrosis and gadolinium-containing radiological contrast agents: an update.
Jalandhara N; Arora R; Batuman V
Clin Pharmacol Ther; 2011 Jun; 89(6):920-3. PubMed ID: 21471962
[No Abstract] [Full Text] [Related]
39. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
Prince MR; Zhang HL; Prowda JC; Grossman ME; Silvers DN
Radiographics; 2009 Oct; 29(6):1565-74. PubMed ID: 19959508
[TBL] [Abstract][Full Text] [Related]
40. Gadolinium-induced nephrogenic systemic fibrosis: communication breakdown among specialists or intuitive stroke of genius?
Kraetschmer K
Intern Med J; 2009 Jan; 39(1):70-2. PubMed ID: 19290991
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
